Regenxbio (RGNX) Cash from Operations Growth (3y) (2017 - 2025)
Regenxbio (RGNX) Cash from Operations Growth (3y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
37.40% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
16.64% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Regenxbio |
325.94 Mn |
95.87 Mn |
- |
-9.92% |
| Date | Value |
|---|
| Dec 31, 2025 |
-9.92% |
| Sep 30, 2025 |
-3.51% |
| Jun 30, 2025 |
7.20% |
| Mar 31, 2025 |
37.53% |
| Dec 31, 2024 |
-27.91% |
| Sep 30, 2024 |
1.56% |
| Jun 30, 2024 |
-8.04% |
| Mar 31, 2024 |
-7.98% |
| Dec 31, 2023 |
-44.75% |
| Sep 30, 2023 |
-10.66% |
| Jun 30, 2023 |
-30.09% |
| Mar 31, 2023 |
-31.51% |
| Dec 31, 2022 |
-15.57% |
| Sep 30, 2022 |
-20.06% |
| Jun 30, 2022 |
-37.51% |
| Mar 31, 2022 |
-24.04% |
| Dec 31, 2021 |
338.80% |
| Sep 30, 2021 |
-29.53% |
| Jun 30, 2021 |
-35.97% |
| Mar 31, 2021 |
-40.23% |
